On October 9, 2026, Nakamoto Inc., a company operating within the Health Care sector and listed on the Nasdaq, filed several amendments to its Form 4 filings with the U.S. Securities and Exchange Commission (SEC). These amendments were necessary to correct typographical errors in the original filings, ensuring that the transactions were accurately recorded as acquisitions of common stock by directors and officers, rather than disposals.
The corrected filings detail the acquisition of additional shares by several key insiders, including the Chief Financial Officer and the Chief Accounting Officer, among other directors. These transactions have resulted in an increase in their total shareholdings. The amendments also provide updated information on the number of shares owned by each insider following these transactions.
As of the close of trading on October 8, 2026, Nakamoto Inc.’s stock was priced at $8.54. The company’s market capitalization stands at $152,820,000 USD. Over the past year, the stock has experienced significant volatility, reaching a 52-week high of $42 on October 27, 2025, and a 52-week low of $3.33 on July 12, 2026.
It is important to note that these filings did not disclose any other material information regarding the company’s operations or financial performance. The focus of the amendments was solely on the correction of the record of stock acquisitions by the company’s insiders.
